Key points are not available for this paper at this time.
Design
Editorial
Answers are grounded in this paper and cite their sources.
Discusses the chronic nature of venous thrombosis and the uncertainty regarding the optimal duration of anticoagulant prophylaxis.
The lethal complication of deep-vein thrombosis is pulmonary embolism. Since about 80 percent of the patients who die of pulmonary embolism succumb within two hours of the onset of symptoms,1 intervention must focus on prevention. Patients who have had a thromboembolic event are at increased risk for recurrence. Oral anticoagulant therapy has up to 90 percent efficacy in preventing repeated episodes. Although the optimal intensity of anticoagulation with warfarin in this situation has been determined,2 generally with an international normalized ratio (INR) of 2.0 to 3.0 set as the target, the optimal duration of prophylaxis has remained uncertain since the . . .
No takes yet. Share an insight, caveat, or question.
Andrew I. Schafer (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: